High-quality , affordable generic products with excellent service

Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider. Viona is marketing and distributing a strong portfolio of oral solids and topicals and has a vast number of products in the development pipeline, which we are excited to introduce to the market in due time! To see the products that we have already introduced into the market, please see our list of products.

Viona has built a team of experienced and committed professionals in all aspects of the business and we have ambitious growth plans for our company.

Our mission is to provide our customers with high quality, affordable generic products with an excellent service level.

MILESTONES

May 2018

Viona Incorporated

May 2019

Viona launches Metronidazole Tablets, USP 250mg & 500mg

July 2019

Viona launches Voriconazole Tablets 50mg & 200mg

September 2019

Viona launches Doxycycline Hyclate Tablets, USP 100mg

December 2019

Viona launches Memantine Hydrochloride Tablets, USP 5mg & 10mg and Metformin Hydrochloride Tablets Extended-Release Tablets, USP 750mg

January 2020

Viona launches Ranolazine Extended-Release Tablets 500mg & 1,000mg

July 2020

Viona launches Acyclovir Ointment, USP 5% and Desonide Cream 0.05%

September 2020

Viona launches Betamethasone Dipropionate Ointment, USP 0.05% and Fluocinonide Cream, USP 0.1%

October 2020

Viona launches Nystatin Ointment, USP

November 2020

Viona launches Desoximetasone Ointment, USP

 

March 2022

Viona launches Doxycycline Hyclate Capsules, USP

 

April 2022

Viona launches Levofloxacin Tablets, USP

 

 

June 2022

Viona launches Adapalene and Benzoyl Peroxide Topical Gel

 

 

July 2022

Viona launches Modafinil Tablets, USP

September 2022

Viona launches Zonisamide Capsules, USP